Therapeutic Account Manager – Kansas City Territory

Therapeutic Account Manager – Kansas City Territory

Reporting to Regional Business Director, the Therapeutic Account Manager (TAM) will be responsible for all sales and marketing activities to the HCP target audiences, Academic Institutions, Hospital Systems, and/or community setting, for the APDS disease state. This role is focused on identifying APDS patients, enrolling them into our product hub, and starting them on Joenja therapy. This position is based in the Kansas City territory serving Oklahoma, Arkansas, Kansas and Missouri.

The Therapeutic Account Manager (TAM) will be responsible for a wide variety of matters in support of Pharming’s growth as we increase the number of both pipeline and marketed products. Core functions include:

• The TAM will be responsible for the implementation of the strategic initiatives developed by the leadership team while developing strong working relationships with all physicians/institutions within their geographic responsibility who treat patients appropriate for the APDS Disease State.

• Primary objective will be identifying providers managing patients where APDS may reside and educate these providers on the APDS disease state along with the value of genetic testing for a definitive diagnosis.

• Ability to effectively penetrate IDNs and carry out institutional selling to Health Care Professionals working within the various Hospital/Institutional settings (i.e. IDNs., referrals, academic and/or research centers, teaching institutions).

• Achieves area sales objectives, market penetration, new patient starts, and revenue targets on a quarterly and annual basis.

• Drives demand through clinical selling and education to referring and treating health care providers on APDS and Leniolisib/Joenja.

• Develops and maintains excellent working relationships with all key stakeholders within Institutions.

• Ensure relationships and respectful engagement with local and regional Patient Advocacy Groups (LPA chapters) working with internal advocacy team.

• Working with other members of the APDS brand team, and facilitating appropriate collaboration with other functions, such as DMS, ACE, Market Access, Ruconest counterparts and other internal stakeholders, as needed.

• Acting in compliance within a highly regulated industry and consistent with training, policies, guidelines, and their own best judgment while adhering to all company policies assigned to the Therapeutic Account Manager position.

• Perform other duties as assigned

• Minimum of 8 or more years selling specialty biologics, preferably Rare Disease, Ultra Orphan, Institutional Sales, or sales within the Hem Onc/Pulmonology/Immunology space.

• Experience working with a Mandatory Hub as well as a Reimbursement Team, is strongly preferred.

• Experience with office-based selling and institutional based selling within newly developed markets and launching new “first in class” products is strongly encouraged.

• Candidates must demonstrate a consistent track record of success (Top 20% performance). President’s Club or other top tier awards preferred.

• Biotech, biologics, and specialty pharmacy experience helpful. Complex sales model experience is a requirement.

• Travel — 50%-75 % travel time required for the position where travel occurs locally or internationally, if applicable.

• Commitment and alignment to Pharming’s mission, core values and behaviors.

We’re built on a simple belief: people living with rare diseases deserve more. Pharming is a global biotechnology company taking on some of the toughest rare disease challenges. We develop and commercialize innovative therapies for rare and ultra-rare immunological and genetic diseases with significant unmet need, where our scientific and commercial expertise, long-term commitment, and real partnership can help advance care.

We put patients at the heart of our work. Their insights, along with those of caregivers, clinicians, scientists, and parters, shape our strategy, guide our decisions, and help turn science into meaningful progress. We keep it simple, act with urgency, and get it done — expanding access to approved therapies, advancing high‑value pipeline…